Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-05-15 OABI / OmniAb, Inc. 4 Cochran Jennifer R. P - Purchase D 1.52 30,000
2025-05-14 CRL / Charles River Laboratories International, Inc. 4 MASSARO GEORGE S - Sale D 145.54 -7
2025-05-14 CRL / Charles River Laboratories International, Inc. 4 MASSARO GEORGE S - Sale D 140.78 -21
2025-05-14 CRL / Charles River Laboratories International, Inc. 4 MASSARO GEORGE S - Sale D 141.85 -14
2025-05-14 CRL / Charles River Laboratories International, Inc. 4 MASSARO GEORGE S - Sale D 139.95 -91
2025-05-14 CRL / Charles River Laboratories International, Inc. 4 MASSARO GEORGE S - Sale D 143.77 -7
2025-05-14 OABI / OmniAb, Inc. 4 Love Steven P - Purchase D 1.46 25,000
2025-05-13 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W S - Sale D 145.41 -500
2025-05-12 NRC / National Research Corporation 4 BEANS PATRICK E P - Purchase D 13.5895 2,500
2025-05-12 NEO / NeoGenomics, Inc. 4 Stone Warren P - Purchase D 8.578 5,700
2025-05-12 OABI / OmniAb, Inc. 4 HIGGINS JOHN L P - Purchase D 1.44 65,000
2025-05-11 NEO / NeoGenomics, Inc. 4 Olivo Alicia C M - Exercise D 6,503
2025-05-11 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 9,613
2025-05-11 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott M - Exercise D 13,005
2025-05-11 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -3,167
2025-05-11 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -2,341
2025-05-11 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,584
2025-05-09 NEO / NeoGenomics, Inc. 4 TETRAULT LYNN A. Lynn Tetrault Rollover IRA P - Purchase I 8.1392 7,000
2025-05-07 NEO / NeoGenomics, Inc. 4 KANOVSKY STEPHEN M P - Purchase D 7.7811 4,000
2025-05-06 NEO / NeoGenomics, Inc. 4 Zook Anthony P. Amended and Restated Anthony P. Zook Living Trust P - Purchase I 7.8793 18,900
2025-05-05 NEO / NeoGenomics, Inc. 4 Gunn Neil P - Purchase D 7.755 4,510
2025-05-05 NEO / NeoGenomics, Inc. 4 Perez David Brian Perez Joint Revocable Trust David & Karen Perez TTEE U/A Dated 12/09/2016 P - Purchase I 7.63 10,000
2025-05-02 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott P - Purchase D 7.5052 20,000
2025-05-02 NEO / NeoGenomics, Inc. 4 Aunan Greg D M - Exercise D 5,372
2025-05-02 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 5,969
2025-05-02 NEO / NeoGenomics, Inc. 4 Aunan Greg D F - Taxes D -1,309
2025-05-02 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -1,454
2025-05-02 CRL / Charles River Laboratories International, Inc. 4 Pease Flavia F - Taxes D 116.89 -889
2025-05-01 NEO / NeoGenomics, Inc. 4 Aunan Greg D F - Taxes D -937
2025-05-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -652
2025-04-24 MEDP / Medpace Holdings, Inc. 4 DAVENPORT FRED B JR S - Sale D 301.82 -1,712
2025-04-24 MEDP / Medpace Holdings, Inc. 4 DAVENPORT FRED B JR M - Exercise D 57.17 4,710
2025-04-24 IQV / IQVIA Holdings Inc. 4 LEONARD JOHN M. A - Award D 1,592
2025-04-24 IQV / IQVIA Holdings Inc. 4 DANHAKL JOHN G By Trust A - Award I 1,592
2025-04-24 IQV / IQVIA Holdings Inc. 4 GOGGINS COLLEEN A A - Award D 1,592
2025-04-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 2 -7,206
2025-04-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 2 -19,382
2025-04-07 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 2 -7,206
2025-04-07 OABI / OmniAb, Inc. 4 Berkman Charles S M - Exercise D 13,542
2025-04-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 36,458
2025-04-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 13,542
2025-04-07 NRC / National Research Corporation 4 Hrdy Helen A - Award D 100,000
2025-04-07 NRC / National Research Corporation 4 Monnich Andrew A - Award D 100,000
2025-04-01 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 2.37 -11,963
2025-04-01 NOTV / Inotiv, Inc. 4 Coelho Mary Theresa S - Sale D 2.3483 -5,500
2025-04-01 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 23,244
2025-04-01 INCY / Incyte Corporation 4 Stein Steven H A - Award D 20,967
2025-04-01 INCY / Incyte Corporation 4 Morrissey Michael James A - Award D 4,649
2025-04-01 INCY / Incyte Corporation 4 Iyengar Vijay K A - Award D 11,159
2025-04-01 INCY / Incyte Corporation 4 Stein Steven H A - Award D 37,198
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)